Research Article

Atherogenic Risk Assessment among Persons Living in Rural Uganda

Table 1

Sociodemographic, clinical, physical, and biochemical characteristics of cohort by gender.

All participantsSex
(%)Male, (%)Female, (%)

All750733784129

Demographic characteristics
Age, in years
13–293679 (49.0)1804 (53.4)1875 (45.4)
30–592978 (39.7)1226 (36.3)1752 (42.4)
60+850 (11.3)348 (10.3)502 (12.2)
Urbanicity score
Quartile 1 (least urban)1978 (26.4)884 (26.2)1094 (26.5)
Quartile 21893 (25.2)848 (25.1)1045 (25.3)
Quartile 31946 (25.9)888 (26.3)1058 (25.6)
Quartile 4 (most urban)1690 (22.5)758 (22.4)932 (22.6)
Highest education level
None/up to P42112 (28.1)876 (25.9)1236 (29.9)
P5–P73365 (44.8)1579 (46.7)1786 (43.3)
Secondary+2030 (27.0)923 (27.3)1107 (26.8)
Occupation
Subsistence crop2975 (39.6)1102 (32.6)1873 (45.4)
Cash crop cultivator934 (12.4)491 (14.5)443 (10.7)
Noncrop1043 (13.9)625 (18.5)418 (10.1)
Unemployed/full-time education2555 (34.0)1160 (34.3)1395 (33.8)
Marital status
Not married/divorced3861 (51.5)1842 (54.6)2019 (48.9)
Married/living3638 (48.5)1532 (45.4)2106 (51.1)

Lifestyle characteristics
Smoking
Never smoked 6747 (89.9)2707 (80.1)4040 (97.8)
Ever smoked daily760 (10.1)671 (19.9)89 (2.2)
Alcohol consumption
Never drinker4844 (64.5)2032 (60.2)2812 (68.1)
Ex-drinker583 (7.8)235 (7.0)348 (8.4)
Current drinker2080 (27.7)1111 (32.9)969 (23.5)

Biophysical characteristics
BMI group
Underweight (<18.5)1701 (22.7)1022 (30.3)679 (16.4)
Normal (18.5–24.9)4878 (65.0)2179 (64.5)2699 (65.4)
Overweight (≥25)730 (9.7)156 (4.6)574 (13.9)
Obese198 (2.6)21 (0.6)177 (4.3)
Waist-hip ratio (WHR)
Normal (≤0.95-m, ≤0.80-f)4440 (59.1)3257 (96.4)1183 (28.7)
Abnormal (>0.95-m, >0.80-f)3067 (40.9)121 (3.6)2946 (71.3)

Biochemical characteristics
Total cholesterol
Desirable (≤5.2 mmol/L)7084 (94.4)3270 (96.8)3814 (92.4)
High (>5.2 mmol/L)423 (5.6)108 (3.2)315 (7.6)
Triglycerides
Desirable (≤2.3 mmol/L)7190 (95.8)3261 (96.5)3929 (95.2)
High (>2.3 mmol/L)317 (4.2)117 (3.5)200 (4.8)
LDL-C
Desirable (≤3.4 mmol/L)7134 (95.0)3286 (97.3)3848 (93.2)
High (>3.4 mmol/L)373 (5.0)92 (2.7)281 (6.8)
HDL-C
Desirable (≥1.04-m, 1.3-f)1940 (25.8)1127 (33.4)813 (19.7)
Undesirable (<1.04-m, 1.3-f), low5567 (74.2)2251 (66.6)3316 (80.3)
HbA1-C
Normal (≤6%)7469 (99.7)3359 (99.8)4110 (99.7)
Raised (≥6.5%)19 (0.3)7 (0.2)12 (0.3)

Clinical characteristics
Hypertension status
Normal BP6163 (82.1)2799 (82.9)3364 (81.5)
Normal BP on treatment173 (2.3)56 (1.7)117 (2.8)
Raised on treatment119 (1.6)31 (0.9)88 (2.1)
Raised BP, not on treatment1050 (14.0)492 (14.6)558 (13.5)
HIV/ART status
Negative6821 (92.0)3103 (93.5)3718 (90.7)
Positive, on ART201 (2.7)63 (1.9)138 (3.4)
Positive, not on ART396 (5.3)152 (4.6)244 (6.0)
Atherogenic risk
Low (<0.1)4341 (57.8)1878 (55.6)2463 (59.7)
Intermediate (0.1–0.24)1259 (16.8)583 (17.3)676 (16.4)
High (>0.24)1907 (25.4)917 (27.1)990 (24.0)

Riha et al. 2014 [26].
8 missing pieces of information.